This website uses cookies to enhance the user experience.
NYKODE THERAPEUTICS ASA

NYKODE THERAPEUTICS ASA990 646 066

Research
Public limited company
Gaustadalléen 21 0349 OSLO, Norge

NYKODE THERAPEUTICS ASA

Home - Nykode
The Nykode Therapeutics platform is built around the Vaccibody molecule: A vaccine platform for the future of medicine.

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Links

Organization

Chairman of the board
Years since formation
18 years
since Jan 13, 2007
Type
Public limited company
VAT registered
Yes
Number of employees
65

Ownership

Number of shares and share classes
326,546,444
1 share class
Total number of shareholders
8553
1,141 companies, 7,412 persons

Financials

Total operating income 2024
9,158,000
NOK
Annual total result 2024
-38,479,000
NOK
Total equity 2024
140,142,000
NOK
Last update: Jun 16, 2025

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Board Member-
Board Member-
Chairman-

Others

NameRoleShares
D
DELOITTE AS
Auditor-
A
AMESTO ACCOUNTHOUSE AS
Accountant-

Top 10 individual shareholders

NameRoleShares
-
4.95 %
directly 0.07 %
indirectly 4.88 %
-
3.95 %
indirectly
-
3.75 %
indirectly
-
2 %
indirectly
-
1.47 %
indirectly
-
1.47 %
indirectly
-
1.37 %
indirectly
-
1.2 %
indirectly
-
1.18 %
directly 0.05 %
indirectly 1.13 %
-
1.04 %
indirectly
Last update: May 8, 2025

Ownership

Company shareholders

NameShare classTotal number of sharesShare
R
RASMUSSENGRUPPEN AS
NO0010714785
30,180,750
9.24 %
D
DATUM OPPORTUNITY AS
NO0010714785
26,000,000
7.96 %
V
VICTORIA INDIA FUND AS
NO0010714785
17,705,175
5.42 %
NO0010714785
15,059,261
4.61 %
N
NORDA ASA
NO0010714785
12,996,755
3.98 %
D
DATUM AS
NO0010714785
12,560,250
3.85 %
J
JOH JOHANNSON EIENDOM AS
NO0010714785
10,561,631
3.23 %
NO0010714785
10,315,311
3.16 %
O
OM HOLDING AS
NO0010714785
6,519,525
2 %
P
PORTIA AS
NO0010714785
4,500,000
1.38 %
K
KRAG INVEST AS
NO0010714785
4,470,100
1.37 %
NO0010714785
3,748,267
1.15 %
A
ALDEN AS
NO0010714785
3,498,445
1.07 %
NO0010714785
2,828,203
0.87 %
NO0010714785
2,753,846
0.84 %
NO0010714785
2,682,839
0.82 %
D
DATUM FINANS AS
NO0010714785
2,395,500
0.73 %
NO0010714785
2,255,034
0.69 %
C
CAABY AS
NO0010714785
2,155,295
0.66 %
F
FOUGNER INVEST AS
NO0010714785
2,004,477
0.61 %
M
MELESIO INVEST AS
NO0010714785
2,000,000
0.61 %
R
RTTM HOLDING AS
NO0010714785
1,900,000
0.58 %
V
VIGINTI AS
NO0010714785
1,882,900
0.58 %
B
BORGANO AS
NO0010714785
1,875,000
0.57 %
C
CIPRIANO AS
NO0010714785
1,775,000
0.54 %
H
HIFO INVEST AS
NO0010714785
1,766,666
0.54 %
NO0010714785
1,609,741
0.49 %
C
CRESSIDA AS
NO0010714785
1,350,000
0.41 %
NO0010714785
1,335,000
0.41 %
T
TIGERSTADEN INVEST AS
NO0010714785
1,250,000
0.38 %
NO0010714785
1,232,944
0.38 %
S
Sirius AS
NO0010714785
1,210,000
0.37 %
NO0010714785
1,193,531
0.37 %
A
ALTITUDE CAPITAL AS
NO0010714785
1,144,500
0.35 %
H
HORTULAN AS
NO0010714785
1,130,000
0.35 %
NO0010714785
1,120,831
0.34 %
S
SKIPS AS TUDOR
NO0010714785
1,100,000
0.34 %
H
HAADEM INVEST AS
NO0010714785
1,100,000
0.34 %
NO0010714785
1,100,000
0.34 %
NO0010714785
1,100,000
0.34 %
NO0010714785
1,021,741
0.31 %
S
SP CAPITAL 22 AS
NO0010714785
1,000,000
0.31 %
S
STAFF-GRUPPEN AS
NO0010714785
1,000,000
0.31 %
NO0010714785
1,000,000
0.31 %
L
LITHINON AS
NO0010714785
1,000,000
0.31 %
S
SONGA CAPITAL AS
NO0010714785
948,979
0.29 %
F
FINYIELD AS
NO0010714785
915,000
0.28 %
NO0010714785
900,059
0.28 %
NO0010714785
890,797
0.27 %
A
ACADIA HOLDING AS
NO0010714785
885,000
0.27 %
N
NORDNET LIVSFORSIKRING AS
NO0010714785
869,773
0.27 %
C
CATILINA INVEST AS
NO0010714785
851,739
0.26 %
T
TRIONOR AS
NO0010714785
840,000
0.26 %
NO0010714785
822,600
0.25 %
O
OLILI AS
NO0010714785
800,000
0.24 %
R
RAMS INVEST AS
NO0010714785
800,000
0.24 %
NO0010714785
771,221
0.24 %
S
STRIGEN AS
NO0010714785
770,000
0.24 %
F
FACULTAS AS
NO0010714785
762,500
0.23 %
N
NASA AS
NO0010714785
750,000
0.23 %
NO0010714785
747,265
0.23 %
C
CARUCEL FINANCE AS
NO0010714785
700,000
0.21 %
KV
NO0010714785
693,707
0.21 %
S
SØNDAGSKJÆRESTE AS
NO0010714785
676,656
0.21 %
NO0010714785
673,821
0.21 %
S
SPÅLEN GENERASJON AS
NO0010714785
650,000
0.2 %
T
TIGERSTADEN AS
NO0010714785
650,000
0.2 %
NO0010714785
610,000
0.19 %
NO0010714785
607,000
0.19 %
K
KRANSTAD INVEST AS
NO0010714785
600,000
0.18 %
K
KARL A HARALDSEN 1 AS
NO0010714785
600,000
0.18 %
NO0010714785
593,000
0.18 %
NO0010714785
551,434
0.17 %
G
GUNNAR LANDGRAFF AS
NO0010714785
550,000
0.17 %
G
GÅSØ NÆRINGSUTVIKLING AS
NO0010714785
550,000
0.17 %
NO0010714785
503,013
0.15 %
L
LIVERMORE INVEST AS
NO0010714785
500,000
0.15 %
E
EHTROD HOLDING AS
NO0010714785
500,000
0.15 %
J
JOF INVEST AS
NO0010714785
500,000
0.15 %
K
KLØVNINGEN AS
NO0010714785
500,000
0.15 %
A
AREPO AS
NO0010714785
500,000
0.15 %
R
RIVERTOWN TRADING AS
NO0010714785
495,000
0.15 %
J
JOMANI AS
NO0010714785
465,228
0.14 %
NO0010714785
459,918
0.14 %
L
LYNX UNLIMITED AS
NO0010714785
454,020
0.14 %
H
H5 VEKST AS
NO0010714785
436,488
0.13 %
S
STRØMME GRUPPEN AS
NO0010714785
430,000
0.13 %
NO0010714785
421,695
0.13 %
W
WESSEL SKIBS AS
NO0010714785
400,000
0.12 %
L
LBM INVEST AS
NO0010714785
400,000
0.12 %
S
STOKO AS
NO0010714785
400,000
0.12 %
E
ELAR CONSULTING AS
NO0010714785
400,000
0.12 %
C
CAMP MYRVOLD AS
NO0010714785
386,240
0.12 %
A
AMANDATOR AS
NO0010714785
382,961
0.12 %
R
REODOR AS
NO0010714785
380,000
0.12 %
U
UFI CAPITAL AS
NO0010714785
370,000
0.11 %
NO0010714785
368,991
0.11 %
P
PRO AS
NO0010714785
368,270
0.11 %
C
CAJO INVEST AS
NO0010714785
365,000
0.11 %
S
SØSTRENE FRIIS AS
NO0010714785
360,000
0.11 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year2024202320222021
Total operating income
9,158,000
13,362,000
9,029,000
35,766,000
Annual Total Result
-38,479,000
-33,392,000
-41,680,000
-8,597,000
Total assets
156,082,000
210,353,000
223,706,000
265,755,000
Total liabilities
15,940,000
35,521,000
64,880,000
70,888,000
Total equity
140,142,000
174,832,000
158,826,000
194,866,000

P&L

Year2024202320222021
Total operating income
9,158,000
13,362,000
9,029,000
35,766,000
Total operating costs
54,906,000
69,842,000
61,177,000
45,682,000
Operating result
-45,748,000
-56,480,000
-52,148,000
-9,916,000
Financial income/costs
547,000
14,051,000
2,148,000
-412,000
Profit before tax
-45,201,000
-42,429,000
-50,000,000
-10,328,000
Total tax & extraordinary income/cost
-6,722,000
-9,037,000
-8,320,000
-1,731,000
Annual Total Result
-38,479,000
-33,392,000
-41,680,000
-8,597,000

Balance overview

Year2024202320222021
Total fixed assets
40,494,000
45,910,000
12,636,000
10,527,000
Total current assets
115,588,000
164,443,000
211,070,000
255,228,000
Total assets
156,082,000
210,353,000
223,706,000
265,755,000
Short term debt
8,083,000
19,855,000
39,406,000
30,754,000
Long term debt
7,857,000
15,666,000
25,474,000
40,134,000
Total liabilities
15,940,000
35,521,000
64,880,000
70,888,000
Contributed capital
144,922,000
141,633,000
83,656,000
89,708,000
Retained earnings
-4,780,000
33,199,000
75,170,000
105,158,000
Total equity
140,142,000
174,832,000
158,826,000
194,866,000
Total equity and liabilities
156,082,000
210,353,000
223,706,000
265,754,000

Classification

Category
Type of organization
Public limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology